A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDevyser Inc.
About this trial
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.
Eligibility criteria
Qualifiers
Willing and able to provide written informed consent
Is 18 years of age or older at enrollment
Had a kidney transplant prior to enrollment
Is having an indication (for cause) biopsy as determined by clinician
Disqualifiers
Is pregnant
Had a blood transfusion within the past 4 weeks
Had a transplant from an identical (monozygotic) twin
Had transplants of multiple organs from the same donor (eg, kidney and liver transplant).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 1 trial groupLocations
6Scripps Health92037, San DiegoCalifornia, United States
University of California San Francisco94143, San FranciscoCalifornia, United States
Piedmont Healthcare30309, AtlantaGeorgia, United States
University of Maryland Baltimore21201, BaltimoreMaryland, United States
Sponsors and collaborators
Devyser Inc.
Lead sponsor
Source ClinicalTrials.gov